Delivery Order SPE2DR25D3303-SPE2DR26F65L2
Award Date 1/12/26
Potential Completion Date 1/13/26
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,570.08 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This is a firm fixed-price, non-set-aside contract performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,944.40 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count packaging) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,731.30 to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled for completion by January 13, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xcopri 50 mg tablets (30-count units) valued at $2,301.29 under a firm fixed-price contract. The award was made on December 15, 2025, with an ultimate completion date of December 16, 2025, and represents a non-competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,262.96 to AmerisourceBergen Drug Corp for the supply of Xcopri 100 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on December 12, 2025, with completion targeted for December 15, 2025, represents a competitive, non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xcopri 100 mg tablets (30-count package) valued at $1,218.35 under a firm fixed-price contract type. The award was made on November 24, 2025, with an ultimate completion date of November 25, 2025, and represents a non-competitive, non-set-aside procurement. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,801.47 on December 18, 2025, for the supply of Xcopri 150 mg tablets (30-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of December 19, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,857.44 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Xcopri 50 mg tablets (30-count units). This firm fixed-price contract, with an ultimate completion date of June 2, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order valued at $2,794.23 to AmerisourceBergen Drug Corp for 30-tablet units of Xcopri 150 mg tablets, with a completion date of September 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,413.60 on August 25, 2025, for the supply of Xcopri 200 mg tablets (30-count). The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. This delivery order is issued under the company's...